EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus‐related cancer incidence by gender and anatomic site of infection
2014/07/17 by Anna R. Giuliano, Alan G. Nyitray, Aimée R. Kreimer +7 · 26 citations
Medicine · #Cervical Cancer and HPV Research #Colorectal and Anal Carcinomas #Head and Neck Cancer Studies
paper · pdf · doi:10.1002/ijc.29082
Abstract
Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and oropharyngeal, anal and penile cancers in men. In this EUROGIN 2014 roadmap, differences in HPV-related cancer and infection burden by gender and anatomic site are reviewed. The proportion of cancers attributable to HPV varies by anatomic site, with nearly 100% of cervical, 88% of anal and <50% of lower genital tract and oropharyngeal cancers attributable to HPV, depending on world region and prevalence of tobacco use. Often, mirroring cancer incidence rates, HPV prevalence and infection natural history varies by gender and anatomic site of infection. Oral HPV infection is rare and significantly differs by gender; yet, HPV-related cancer incidence at this site is several-fold higher than at either the anal canal or the penile epithelium. HPV seroprevalence is significantly higher among women compared to men, likely explaining the differences in age-specific HPV prevalence and incidence patterns observed by gender. Correspondingly, among heterosexual partners, HPV transmission appears higher from women to men. More research is needed to characterize HPV natural history at each anatomic site where HPV causes cancer in men and women, information that is critical to inform the basic science of HPV natural history and the development of future infection and cancer prevention efforts.
Cited by
- Sex Differences in the Incidence and Clearance of Anogenital Human Papillomavirus Infection in Liuzhou, China: An Observational Cohort Study
- NHANES 2009-2012 Findings: Association of Sexual Behaviors with Higher Prevalence of Oral Oncogenic Human Papillomavirus Infections in U.S. Men. [europepmc]
- Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. [europepmc]
- Seroconversion Following Anal and Genital HPV Infection in Men: The HIM Study . [europepmc]
- HPV Positive Head and Neck Cancers: Molecular Pathogenesis and Evolving Treatment Strategies. [europepmc]
- Human papillomavirus infection and vaccination: Knowledge and attitudes among young males in Italy. [europepmc]
- HPV infection among a population-based sample of sexual minority women from USA. [europepmc]
- Risk Factors for Oral Human Papillomavirus Infection in Healthy Individuals: A Systematic Review and Meta-Analysis. [europepmc]
- Autophagy regulates UBC9 levels during viral-mediated tumorigenesis. [europepmc]
- Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy. [europepmc]
- Associations Between Sexual Orientation and Overall and Site-Specific Diagnosis of Cancer: Evidence From Two National Patient Surveys in England. [europepmc]
- Oral Human Papillomavirus Infection: Differences in Prevalence Between Sexes and Concordance With Genital Human Papillomavirus Infection, NHANES 2011 to 2014. [europepmc]
- Prevalence of Genital Human Papillomavirus Among Sexually Experienced Males and Females Aged 14-59 Years, United States, 2013-2014. [europepmc]
- Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review). [europepmc]
- Primary care pediatricians' attitudes and practice towards HPV vaccination: A nationwide survey in Italy. [europepmc]
- Human Papilloma Virus and Autophagy. [europepmc]
- HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa. [europepmc]
- Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers. [europepmc]
- Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV + Cancers. [europepmc]
- Human Papillomavirus Genotype Replacement: Still Too Early to Tell? [europepmc]
- Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis. [europepmc]
- Genome-Wide Sex and Gender Differences in Cancer. [europepmc]
- Estimated Prevalence and Incidence of Disease-Associated Human Papillomavirus Types Among 15- to 59-Year-Olds in the United States. [europepmc]
- Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan. [europepmc]
- Sex Differences in the Prevalence of Head and Neck Cancers: A 10-Year Follow-Up Study of 10 Million Healthy People. [europepmc]
- Prevention and treatment of human papillomavirus in men benefits both men and women. [europepmc]
Related